 | Up a level |
2017
Nogova, Lucia, Malchers, Florian, Bitter, Elisabeth, Michels, Sebastian Yves Friedrich, Fischer, Rieke Nila, Scheffler, Matthias, Gardizi, Masyar, Brandes, Vanessa, Scheel, Andreas H., Kambartel, Karl -Otto, Krueger, Stefan, Serke, Monika Heidi, Isaacs, Randi, Porter, Dale, Buettner, Reinhard, Thomas, Roman K. and Wolf, Juergen (2017). Fibroblast kinase 1-3 inhibitor BGJ398 in patients with FGFR1 amplified squamous non-small cell lung cancer treated in a phase I study: Evaluation of tumor tissue and response at a single center. J. Clin. Oncol., 35. ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
2014
Michels, Sebastian Yves Friedrich, Scheffler, Matthias, Gardizi, Masyar, Christiaan, Marc, Bos, Allardt, Nogova, Lucia, Koenig, Katharine, Fassunke, Jana, Heydt, Carina, Michaela, Ihle, Kuenstlinger, Helen, Toepit, Karin, Ueckeroth, Frank, Albus, Kerstin, Serke, Monika Heidi, Randerath, Winfried, Engel-Riedel, Walburga, Merkelbach-Bruse, Sabine, Heukamp, Lukas Carl, Buettner, Reinhard and Wolf, Juergen (2014). Clinical and molecular characteristics of non-small cell lung cancer patients harboring PIK3CA mutations. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Nogova, Lucia, Gardizi, Masyar, Christiaan, Marc, Bos, Allardt, Scheffler, Matthias, Mattonet, Christian, Heukamp, Lukas Carl, Schildhaus, Hans-Ulrich, Fuhr, Uwe, Eberhardt, Wilfried, Reis, Henning, Wiesweg, Marcel, Schmid, Kurt Werner, Schoch, Gernot, Ko, Yon-Dschun, Serke, Monika Heidi, Schuler, Martin H., Buettner, Reinhard and Wolf, Juergen (2014). TRY: A phase II study to evaluate safety and efficacy of combined trastuzumab and AUY922 in advanced non-small cell lung cancer (NSCLC) with HER2 overexpression or amplification or mutation. J. Clin. Oncol., 32 (15). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755